Functional analysis of in vivo and in organello footprinting of HeLa cell mitochondrial DNA in relationship to ATP and ethidium bromide effects on transcription.
In vivo and in organello footprinting techniques based on methylation interference have been utilized to investigate protein-DNA interactions in the transcription initiation and rDNA transcription termination regions of human mitochondrial DNA (mtDNA) in functionally active mitochondria. In particular, the changes in methylation reactivity of these regions in response to treatment of the organelles with ATP or ethidium bromide, which affects differentially the rates of mitochondrial rRNA and mRNA synthesis, have been analyzed. Two major sites of protein-DNA interactions have been identified in the main control region of mtDNA, both in vivo and in organello, which correspond to the regions of the light-strand promoter and heavy-strand rRNA-specific promoter. The in organello footprinting of the latter showed ATP- and ethidium bromide-dependent modifications that could be correlated with changes in the rate of rRNA but not of mRNA synthesis. By contrast, no ATP effects were observed on the in organello footprinting pattern of the termination region and on in vitro transcription termination, strongly suggesting that ATP control of rRNA synthesis occurs at the initiation level. Several methylation interference sites were found upstream of the whole H-strand transcription unit, pointing to possible protein-DNA interactions related to the activity of this unit. In vivo footprinting of the rDNA transcription termination region of human mtDNA has revealed a very strong protection pattern, indicating a high degree of occupancy of the termination site by mitochondrial transcription termination factor (approximately 80%).
Micol
V
V
Division of Biology, California Institute of Technology, Pasadena, California 91125, USA.
Fernández-Silva
P
P
Attardi
G
G
D000255:Adenosine Triphosphate / Q000008:administration & dosage / Q000494:pharmacology*; D001483:Base Sequence; D050976:Basic-Leucine Zipper Transcription Factors; D004247:DNA / Q000378:metabolism; D018983:DNA Footprinting; D019175:DNA Methylation; D004272:DNA, Mitochondrial / Q000737:chemistry / Q000187:drug effects / Q000378:metabolism*; D004275:DNA, Ribosomal / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D004996:Ethidium / Q000494:pharmacology*; D006367:HeLa Cells; D006801:Humans; D007364:Intercalating Agents / Q000494:pharmacology; D016350:Leucine Zippers; D024101:Mitochondrial Proteins; D008969:Molecular Sequence Data; D011401:Promoter Regions, Genetic; D012313:RNA / Q000096:biosynthesis; D014157:Transcription Factors / Q000378:metabolism; D014158:Transcription, Genetic / Q000187:drug effects*; D014544:Uridine Triphosphate / Q000378:metabolism
D050976:Basic-Leucine Zipper Transcription Factors; D004272:DNA, Mitochondrial; D004275:DNA, Ribosomal; D007364:Intercalating Agents; C105178:MTERF1 protein, human; D024101:Mitochondrial Proteins; D014157:Transcription Factors; D012313:RNA; D000255:Adenosine Triphosphate; D004247:DNA; D004996:Ethidium; D014544:Uridine Triphosphate